Literature DB >> 7586720

High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors.

R Lenkei1, B Andersson.   

Abstract

Blood samples of 58 blood donors (ages 19-64 years, 31 males and 27 females) were investigated with three-color, quantitative flow cytometry. IgG anti-cytomegalovirus (CMV) was estimated with ELISA. Nineteen men and 21 women were found CMV-seropositive. The seropositive individuals (CMV-pos) compared to the seronegative ones (CMV-neg) presented no significant changes in the absolute number of lymphocytes or in the main lymphocyte subpopulations identified by CD20, CD3, CD4, and CD8. Nevertheless, CMV-pos showed significantly higher numbers of lymphocytes with the following phenotypes: CD4+HLA-DR+, CD8+HLA-DR+, CD8+CD45RA+ CD45RO+, and CD20+CD5+. The CD3+CD57+ subset of T lymphocytes was also significantly higher in CMV-pos (P < 0.0001), whereas the CD57+CD16 &amp; CD56+CD3- NKC subset presented similar values in both groups. Higher values for the antibody-binding capacity of lymphocytes CD38 (P < 0.05) and CD45 (P = 0.02) antigens and of CD57 antigen on CD3+ lymphocytes (P < 0.0005) were found in the CMV-pos group. These results show that CMV upregulates the number of CD57 molecules on CD3+ and not on CD3- lymphocytes and suggest that the CD3 molecule or other molecules specifically present in T cells can play a role in CMV latency. The study also showed that CMV plays a major role in the maintenance of a fraction of lymphocyte in the activated state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586720     DOI: 10.1006/clin.1995.1136

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  10 in total

Review 1.  Role of immune activation in HIV pathogenesis.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

2.  Progressive decrease of CD8high+ CD28+ CD57- cells with ageing.

Authors:  J Merino; M A Martínez-González; M Rubio; S Inogés; A Sánchez-Ibarrola; M L Subirá
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Lorrie Epling; Juli Teague; Mark A Jacobson; Russell P Tracy; Lawrence Corey; Steven G Deeks
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

4.  Pathological findings in human autoimmune lymphoproliferative syndrome.

Authors:  M S Lim; S E Straus; J K Dale; T A Fleisher; M Stetler-Stevenson; W Strober; M C Sneller; J M Puck; M J Lenardo; K S Elenitoba-Johnson; A Y Lin; M Raffeld; E S Jaffe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

5.  Associations between virologic and immunologic dynamics in blood and in the male genital tract.

Authors:  Sara Gianella; Matthew C Strain; Steffney E Rought; Milenka V Vargas; Susan J Little; Douglas D Richman; Celsa A Spina; Davey M Smith
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

6.  Immunosenescence and gender: a study in healthy Cubans.

Authors:  Beatriz García Verdecia; Danay Saavedra Hernández; Patricia Lorenzo-Luaces; Teresita de Jesús Badía Alvarez; Idrissa Leonard Rupalé; Zaima Mazorra Herrera; Tania Crombet Ramos; Agustín Lage Dávila
Journal:  Immun Ageing       Date:  2013-04-30       Impact factor: 6.400

7.  Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients.

Authors:  Elvira Jimenez Vera; Yi Vee Chew; Leigh Nicholson; Heather Burns; Patricia Anderson; Hsiao-Ting Chen; Lindy Williams; Karen Keung; Negar Talaei Zanjani; Suat Dervish; Ellis Patrick; Xin Maggie Wang; Shounan Yi; Wayne Hawthorne; Stephen Alexander; Philip J O'Connell; Min Hu
Journal:  PLoS One       Date:  2019-05-22       Impact factor: 3.240

8.  Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.

Authors:  Denise C Hsu; Stephen J Kerr; Thatri Iampornsin; Sarah L Pett; Anchalee Avihingsanon; Parawee Thongpaeng; John J Zaunders; Sasiwimol Ubolyam; Jintanat Ananworanich; Anthony D Kelleher; David A Cooper
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

9.  Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.

Authors:  Mathias Streitz; Tewfik Miloud; Michael Kapinsky; Michael R Reed; Robert Magari; Edward K Geissler; James A Hutchinson; Katrin Vogt; Stephan Schlickeiser; Anders Handrup Kverneland; Christian Meisel; Hans-Dieter Volk; Birgit Sawitzki
Journal:  Transplant Res       Date:  2013-10-25

10.  Effects of Fish Oil on HIV-Related Inflammation and Markers of Immunosenescence: A Randomized Clinical Trial.

Authors:  Barbara Swanson; Joyce Keithley; Linda Baum; Sue Leurgans; Oluwatoyin Adeyemi; Lisa L Barnes; Mariana Mata; Anneliese Rosdil
Journal:  J Altern Complement Med       Date:  2018-05-15       Impact factor: 2.579

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.